These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3317356)

  • 1. Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
    Crovari P; Crovari PC; Petrilli RC; Icardi GC; Bonanni P
    Postgrad Med J; 1987; 63 Suppl 2():161-4. PubMed ID: 3317356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M; Berger R; Just V
    Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a recombinant yeast-derived hepatitis B vaccine in healthy adults.
    Scheiermann N; Gesemann KM; Kreuzfelder E; Paar D
    Postgrad Med J; 1987; 63 Suppl 2():115-9. PubMed ID: 3317345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.
    Wiedermann G; Ambrosch F; Kremsner P; Kunz C; Hauser P; Simoen E; André F; Safary A
    Postgrad Med J; 1987; 63 Suppl 2():109-13. PubMed ID: 3317344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of yeast-derived hepatitis B vaccines in young adults.
    Bergamini F; Zanetti A
    Postgrad Med J; 1987; 63 Suppl 2():137-8. PubMed ID: 3317349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
    Meheus A; Alisjahbana A; Vranckx R; Sukadi A; Usman A; Ngantung W; Sugita E; Safary A; André F; Reniers J
    Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.
    Bruguera M; Cremades M; Mayor A; Sánchez Tapias JM; Rodés J
    Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
    Prinsen H; Goilav C; Safary A; André FE; Piot P
    Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.
    André FE; Safary A
    Postgrad Med J; 1987; 63 Suppl 2():169-77. PubMed ID: 3317357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers.
    Goudeau A; Denis F; Mounier M; Dubois F; Klein J; Godefroy A; Ballet M; Mountij A
    Postgrad Med J; 1987; 63 Suppl 2():125-8. PubMed ID: 3317347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast-derived hepatitis B vaccine in thalassaemic patients: a preliminary report.
    Giammanco G; De Grandi V; Pignato S; Dolci C; Congia M; Pisu C; De Virgiliis S
    Postgrad Med J; 1987; 63 Suppl 2():151-4. PubMed ID: 3317353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization against hepatitis B: immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males.
    Laukamm-Josten U; von Laer G; Feldmeier H; Bienzle U; Uy A; Thomssen R; Guggenmoos-Holzmann I
    Postgrad Med J; 1987; 63 Suppl 2():143-6. PubMed ID: 3317351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.
    Ambrosch F; Frisch-Niggemeyer W; Kremsner P; Kunz C; André F; Safary A; Wiedermann G
    Postgrad Med J; 1987; 63 Suppl 2():129-35. PubMed ID: 3317348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine.
    Cadranel S; Zeghlache S; Fernandez S; Safary A; André F
    Postgrad Med J; 1987; 63 Suppl 2(736):159-60. PubMed ID: 3317355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development of a new recombinant DNA hepatitis B vaccine.
    Safary A; André F
    Postgrad Med J; 1987; 63 Suppl 2():105-7. PubMed ID: 3317343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
    Schellekens H; de Reus A; Peetermans JH; van Eerd PA
    Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.